Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina Pectoris

Figure 2

Factors associated with β-blocker use in multivariable analysis. Variables associated with β-blocker use are shown along the vertical axis. The strength of effect is shown along the horizontal axis with the vertical line demarcating an odds ratio (OR) of 1 (i.e., no association); estimates to the right (i.e., >1) are associated with a greater likelihood of β-blocker use, whereas those to the left (i.e., <1) indicate a reduced likelihood of β-blocker use. Each dot represents the point estimate of the effect of that variable in the model, whereas the line shows the 95% confidence interval (CI). BMI, body mass index; DM, diabetes mellitus; OMI, old myocardial infarction; PCI, percutaneous coronary intervention; HR, heart rate; eGFR, estimated glomerular filtration rate; TG, triglyceride; LVEF, left ventricular ejection fraction; LM, left main trunk; CTO, chronic total occlusions; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.